Background Snakebite is a neglected tropical disease with almost all its burden being concentrated in South Asia and Africa. Every year 81,000–138,000 people die due to snakebite globally, almost half of them in India. The World Health Organisation has in 2019 developed a strategy to address the burden of snakebite. It has four pillars: empower and engage communities. ensure safe, effective treatment. strengthen health systems. increase partnerships, coordination and resource sharing. While community-based interventions are very common there is no evidence synthesis on the effectiveness of it. The current project fills this gap. Aim To assess the effectiveness of community-based interventions for addressing the burden of snakebite Research Methodology Community based interventions for snakebite represents a complex public health intervention. The project will focus on conduct of a high-quality systematic review of intervention studies, in accordance with broad principles and

BackgroundCOHESION-I, a unique collaborative research initiative, is being implemented across Peru, Mozambique, Nepal, and India. Its primary focus is on understanding and enhancing the responsiveness of health systems. In India, the project takes a distinct approach, targeting the rural communities in the states of Telangana and Chhattisgarh. It will engage local communities in co-designing and implementing strategies to improve access to and utilisation of primary health care services provided by the public health system.The COHESION-I project aims to comprehensively understand primary healthcare responses for tracer conditions such as hypertension and diabetes mellitus for non-communicable diseases (NCDs) and lymphatic filariasis for neglected tropical diseases (NTDs). This research is crucial as it addresses pressing health challenges in low-resource settings, emphasising community engagement and participatory approaches. By focusing on national priorities such as improving primary health care and address

BackgroundSGLT2 inhibitors are a relatively new class of agents, originally developed as oral antihyperglycemic drugs. SGLT2 inhibitors are clinically available since 2012 for the treatment of patients with diabetes mellitus type 2. Later, SGLT2 inhibitors appeared to also have specific reno- and cardioprotective effects. Notably, the trials that have been performed thus far have excluded patients with an eGFR below 25 mL/min/1.73m2 at inclusion, prevalent dialysis patients, and kidney transplant recipients. These patients are at greater risk of developing kidney failure requiring dialysis, cardiovascular complications and mortality, however currently there are only a few proven effective therapies for these conditions. There is emerging evidence from experimental studies and post hoc-analyses of randomised clinical trials that SGLT2 inhibitors may also be effective in preventing cardiovascular and mortality outcomes in patients with severe CKD, including patients receiving dialysis or living with a

BackgroundFood and water insecurity are critical factors contributing to poor nutrition and impacting planetary health. When communities lack access to an adequate and diverse food supply or clean water, they often resort to consuming nutritionally deficient options, leading to malnutrition and its associated health issues.By tackling these interconnected challenges, we can improve nutrition outcomes and safeguard the health of both people and the planet.AimThe overall goal of this five-year program is to mobilise communities and support them to transform local food systems.With a focus on remote communities in Australia, the Pacific Islands and India, this program will support communities to measure the impact of community-led initiatives to strengthen food and water security.Research Methodology:The program will the Household Food Insecurity Access Index Scale (HFIAS) and the Household Water Security Index Scale (HWISE) which are internationally recognised tools, to measure food and water security in commun